Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

Research output: Contribution to journalJournal articleResearchpeer-review

  • Delphine Casabonne
  • Yolanda Benavente
  • Julia Seifert
  • Laura Costas
  • Maria Armesto
  • Maria Arestin
  • Caroline Besson
  • Fatemeh S. Hosnijeh
  • Eric J. Duell
  • Elisabete Weiderpass
  • Giovanna Masala
  • Rudolf Kaaks
  • Federico Canzian
  • Maria-Dolores Chirlaque
  • Vittorio Perduca
  • Francesca R. Mancini
  • Valeria Pala
  • Antonia Trichopoulou
  • Anna Karakatsani
  • Carlo La Vecchia
  • Maria-Jose Sanchez
  • Rosario Tumino
  • Marc J. Gunter
  • Pilar Amiano
  • Salvatore Panico
  • Carlotta Sacerdote
  • Julie A. Schmidt
  • Heiner Boeing
  • Matthias B. Schulze
  • Aurelio Barricarte
  • Elio Riboli
  • Anja Olsen
  • Roel Vermeulen
  • Alexandra Nieters
  • Charles H. Lawrie
  • Silvia de Sanjose
Original languageEnglish
JournalInternational Journal of Cancer
ISSN0020-7136
DOIs
Publication statusE-pub ahead of print - 2020

    Research areas

  • chronic lymphocytic leukemia, circulating miRNA, serum, prospective study

ID: 237410427